Showing results (101-110 of 167) with videos related to
Sort By:
Pageof 17
European Journal of Pharmacology|November 24, 2004
Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the ratShona L Kirk, Joanna C Neill, Declan N C Jones, et al.Virology|December 1, 1989
C-terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation immunityD Urbanelli, Y Sawada, J Raskova, et al.The Journal of Reproductive Medicine|August 1, 1986
Use of tracheloscopy and directed biopsy for evaluating cervical involvement in endometrial carcinomaI Jelen, B Anderson, N C Jones, et al.Neuropharmacology|January 17, 2012
Short-term individual housing induced social deficits in female Mongolian gerbils: attenuation by chronic but not acute imipramineA R Pickles, J J Hagan, D N C Jones, et al.Physical Review Letters|October 10, 2006
Rotational excitation of H2O by cold electronsR Curík, J P Ziesel, N C Jones, et al.Journal of the National Medical Association|August 1, 1981
Tuberculosis presenting as a pelvis massN C Jones, E W Savage, F Salem, et al.Psychopharmacology|December 7, 2007
The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activityM L Woolley, D J Pemberton, S Bate, et al.The European Journal of Neuroscience|September 27, 2003
Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonismLaura Wiseman Harris, Trevor Sharp, Jane Gartlon, et al.Molecular Endocrinology (Baltimore, Md.)|February 1, 1995
Activating transcription factor-1 is a specific antagonist of the cyclic adenosine 3'.5'-monophosphate (cAMP) response element-binding protein-1-mediated response to cAMPM J Ellis, A C Lindon, K J Flint, et al.European Journal of Pharmacology|June 11, 2004
Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brainJane E Gartlon, Tracey Ashmeade, Mark Duxon, et al.Pageof 17